바이오모아 (BioMoa) — ADC · Antibody

9268프로그램 35FDA 승인

1오늘 방문

739누적 방문

8122갱신 대기 S–CData Tier S/A/B차세대 1068HER2 breast 5456Antibody 2744CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

AntibodystaleRochePhase 1

Bevacizumab, Everolimus and LBH589 (Bevacizumab, Everolimus and LBH589)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase1#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleRochePhase 1

bevacizumab with chemotherapy, Pleur-XTM catheter placement (bevacizumab with chemotherapy, Pleur-XTM catheter placement)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase1#항체#면역항체+4

임상시험 1상태 ACTIVE

AntibodyBiologicstaleRochePhase 1

aka Avastin or Rhu MAb VEGF (Bevacizumab, Bevacizumab (aka Avastin or Rhu MAb VEGF))

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleRochePhase 2

Bevacizumab Plus Capecitabine (Bevacizumab Plus Capecitabine)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleRochePhase 2

Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab (Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab)

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleUMC UtrechtPhase 2

FTD-TPI and bevacizumab (Systemic treatment, Systemic treatment (FTD-TPI and bevacizumab))

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 RECRUITING

AntibodystaleUniversity Hospital, CaenPhase 2

bevacuzimab spray (bevacuzimab spray)

Telangiectasia, Hereditary Hemorrhagic · Telangiectasia, Hereditary Hemorrhagic

#TelangiectasiaHereditaryHemorrha#Antibody#Phase2#항체#면역항체+4

임상시험 1상태 ACTIVE

AntibodystaleHebei Yanda HospitalPreclinical

Ultra-low dose Bevacizumab (Ultra-low dose Bevacizumab)

Recurrent High-grade Glioma · Recurrent High-grade Glioma

#RecurrentHigh-gradeGlioma#Antibody#Preclinical#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleKhon Kaen UniversityPhase 3

Intralesional injection of bevacizumab (Intralesional injection of bevacizumab)

Pterygium; Inflammation · Pterygium

#Pterygium#Antibody#Phase3#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystaleProgen PharmaceuticalsPhase 1

CGC-11047 and bevacizumab (CGC-11047 and bevacizumab)

Cancer · Cancer

#Cancer#Antibody#Phase1#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleKaty PetersPhase 2

Vorinostst/Bevacizumab/Temozolomide (Vorinostst/Bevacizumab/Temozolomide)

Brain Tumor; Glioblastoma · Brain Tumor

#BrainTumor#Antibody#Phase2#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystaleLei LiPhase 2

Albumin-bound paclitaxel and bevacizumab (Albumin-bound paclitaxel and bevacizumab)

Ovarian Carcinoma; Platinum-resistant Ovarian Cancer · Ovarian Carcinoma

#OvarianCarcinoma#Antibody#Phase2#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystaleFudan UniversityPreclinical

DEBIRI Combined With Chemotherapy and Bevacizumab (DEBIRI Combined With Chemotherapy and Bevacizumab)

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Preclinical#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystalePPD Development, LPPhase 2

Cohort A: vilobelimab (Cohort A: vilobelimab)

Acute Respiratory Distress Syndrome (ARDS); ARDS · Acute Respiratory Distress Syndrome (ARD

#AcuteRespiratoryDistressSyndrome#Antibody#Phase2#항체#면역항체+3

임상시험 1상태 RECRUITING

AntibodystaleSaglik Bilimleri UniversitesiPreclinical

ranibizumab (Lucentis, dexamethasone implant versus ranibizumab)

Diabetic Macular Edema; Inflammation · Diabetic Macular Edema

#DiabeticMacularEdema#Antibody#Preclinical#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystalemAbxience Research S.L.Phase 1

Bevacizumab Biosimilar (MB02, MB02 (Bevacizumab Biosimilar))

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleCaigang LiuPhase 3

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 RECRUITING

AntibodystaleTesaro, Inc.Phase 3

TSR-042 (Dostarlimab, Dostarlimab (TSR-042))

Ovarian Neoplasms; Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma · Ovarian Neoplasms

#OvarianNeoplasms#Antibody#Phase3#항체#면역항체+4

효능 ORR 88%임상시험 1상태 RECRUITING

AntibodystaleRegeneronPreclinical

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept [Eylea])

AMD · AMD

#AMD#Antibody#Preclinical#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleRochePhase 2

Bevacizumab, Oxaliplatin, Pemetrexed (Bevacizumab, Oxaliplatin, Pemetrexed)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleNorton HealthcarePhase 2

Low-dose Intra-arterial Bevacizumab (Low-dose Intra-arterial Bevacizumab)

Radiation Necrosis · Radiation Necrosis

#RadiationNecrosis#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleEastern Regional Medical CenterPhase 1

Intraperitoneal Bevacizumab (Intraperitoneal Bevacizumab)

Malignant Ascites · Malignant Ascites

#MalignantAscites#Antibody#Phase1#항체#면역항체+2

임상시험 1상태 DISCONTINUED

AntibodystaleCedars-Sinai Medical CenterPhase 1

Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab (Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab)

Glioblastoma; Glioblastoma Multiforme · Glioblastoma

#Glioblastoma#Antibody#Phase1#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystaleRochePhase 3

Bevacizumab cycles 3 onwards (Bevacizumab cycles 3 onwards)

Colorectal Carcinoma; Liver Metastases · Colorectal Carcinoma

#ColorectalCarcinoma#Antibody#Phase3#항체#면역항체+3

임상시험 1상태 DISCONTINUED

AntibodystaleRoswell Park Cancer InstitutePhase 2

Gemcitabine, Capecitabine and Bevacizumab (Gemcitabine, Capecitabine and Bevacizumab)

Cholangiocarcinoma · Cholangiocarcinoma

#Cholangiocarcinoma#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 ACTIVE

100 / 167 페이지

← 이전 다음 →

전체 9,268개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 1 / 739

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

Bevacizumab, Everolimus and LBH589 (Bevacizumab, Everolimus and LBH589)

bevacizumab with chemotherapy, Pleur-XTM catheter placement (bevacizumab with chemotherapy, Pleur-XTM catheter placement)

aka Avastin or Rhu MAb VEGF (Bevacizumab, Bevacizumab (aka Avastin or Rhu MAb VEGF))

Bevacizumab Plus Capecitabine (Bevacizumab Plus Capecitabine)

Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab (Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab)

FTD-TPI and bevacizumab (Systemic treatment, Systemic treatment (FTD-TPI and bevacizumab))

bevacuzimab spray (bevacuzimab spray)

Ultra-low dose Bevacizumab (Ultra-low dose Bevacizumab)

Intralesional injection of bevacizumab (Intralesional injection of bevacizumab)

CGC-11047 and bevacizumab (CGC-11047 and bevacizumab)

Vorinostst/Bevacizumab/Temozolomide (Vorinostst/Bevacizumab/Temozolomide)

Albumin-bound paclitaxel and bevacizumab (Albumin-bound paclitaxel and bevacizumab)

DEBIRI Combined With Chemotherapy and Bevacizumab (DEBIRI Combined With Chemotherapy and Bevacizumab)

Cohort A: vilobelimab (Cohort A: vilobelimab)

ranibizumab (Lucentis, dexamethasone implant versus ranibizumab)

Bevacizumab Biosimilar (MB02, MB02 (Bevacizumab Biosimilar))

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

TSR-042 (Dostarlimab, Dostarlimab (TSR-042))

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept [Eylea])

Bevacizumab, Oxaliplatin, Pemetrexed (Bevacizumab, Oxaliplatin, Pemetrexed)

Low-dose Intra-arterial Bevacizumab (Low-dose Intra-arterial Bevacizumab)

Intraperitoneal Bevacizumab (Intraperitoneal Bevacizumab)

Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab (Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab)

Bevacizumab cycles 3 onwards (Bevacizumab cycles 3 onwards)

Gemcitabine, Capecitabine and Bevacizumab (Gemcitabine, Capecitabine and Bevacizumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

Bevacizumab, Everolimus and LBH589 (Bevacizumab, Everolimus and LBH589)

bevacizumab with chemotherapy, Pleur-XTM catheter placement (bevacizumab with chemotherapy, Pleur-XTM catheter placement)

aka Avastin or Rhu MAb VEGF (Bevacizumab, Bevacizumab (aka Avastin or Rhu MAb VEGF))

Bevacizumab Plus Capecitabine (Bevacizumab Plus Capecitabine)

Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab (Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab)

FTD-TPI and bevacizumab (Systemic treatment, Systemic treatment (FTD-TPI and bevacizumab))

bevacuzimab spray (bevacuzimab spray)

Ultra-low dose Bevacizumab (Ultra-low dose Bevacizumab)

Intralesional injection of bevacizumab (Intralesional injection of bevacizumab)

CGC-11047 and bevacizumab (CGC-11047 and bevacizumab)

Vorinostst/Bevacizumab/Temozolomide (Vorinostst/Bevacizumab/Temozolomide)

Albumin-bound paclitaxel and bevacizumab (Albumin-bound paclitaxel and bevacizumab)

DEBIRI Combined With Chemotherapy and Bevacizumab (DEBIRI Combined With Chemotherapy and Bevacizumab)

Cohort A: vilobelimab (Cohort A: vilobelimab)

ranibizumab (Lucentis, dexamethasone implant versus ranibizumab)

Bevacizumab Biosimilar (MB02, MB02 (Bevacizumab Biosimilar))

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

TSR-042 (Dostarlimab, Dostarlimab (TSR-042))

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept [Eylea])

Bevacizumab, Oxaliplatin, Pemetrexed (Bevacizumab, Oxaliplatin, Pemetrexed)

Low-dose Intra-arterial Bevacizumab (Low-dose Intra-arterial Bevacizumab)

Intraperitoneal Bevacizumab (Intraperitoneal Bevacizumab)

Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab (Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab)

Bevacizumab cycles 3 onwards (Bevacizumab cycles 3 onwards)

Gemcitabine, Capecitabine and Bevacizumab (Gemcitabine, Capecitabine and Bevacizumab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

Bevacizumab, Everolimus and LBH589 (Bevacizumab, Everolimus and LBH589)

bevacizumab with chemotherapy, Pleur-XTM catheter placement (bevacizumab with chemotherapy, Pleur-XTM catheter placement)

aka Avastin or Rhu MAb VEGF (Bevacizumab, Bevacizumab (aka Avastin or Rhu MAb VEGF))

Bevacizumab Plus Capecitabine (Bevacizumab Plus Capecitabine)

Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab (Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab)

FTD-TPI and bevacizumab (Systemic treatment, Systemic treatment (FTD-TPI and bevacizumab))

bevacuzimab spray (bevacuzimab spray)

Ultra-low dose Bevacizumab (Ultra-low dose Bevacizumab)

Intralesional injection of bevacizumab (Intralesional injection of bevacizumab)

CGC-11047 and bevacizumab (CGC-11047 and bevacizumab)

Vorinostst/Bevacizumab/Temozolomide (Vorinostst/Bevacizumab/Temozolomide)

Albumin-bound paclitaxel and bevacizumab (Albumin-bound paclitaxel and bevacizumab)

DEBIRI Combined With Chemotherapy and Bevacizumab (DEBIRI Combined With Chemotherapy and Bevacizumab)

Cohort A: vilobelimab (Cohort A: vilobelimab)

ranibizumab (Lucentis, dexamethasone implant versus ranibizumab)

Bevacizumab Biosimilar (MB02, MB02 (Bevacizumab Biosimilar))